Which blood test would you monitor in patients receiving anticoagulant therapy?

• A. Platelet count
• B. Prothrombin time (PT)
• C. Sodium level
• D. Magnesium level

Answer: (B)

Monitoring prothrombin time (PT) is essential in patients receiving anticoagulant therapy, particularly when using vitamin K antagonists such as warfarin. PT reflects the time it takes for blood to clot and is used to assess the effectiveness of anticoagulant treatment. Since anticoagulants aim to prolong the coagulation times to prevent thrombosis, measuring PT helps ensure that patients remain within a therapeutic range—avoiding both inadequate anticoagulation, which increases the risk of clot formation, and excessive anticoagulation, which can lead to bleeding complications.

Other tests like platelet count are relevant in monitoring for specific types of anticoagulant therapy, such as heparin-induced thrombocytopenia, but they do not directly measure the anticoagulant effect of medications like warfarin. Sodium and magnesium levels do not provide information relevant to anticoagulation management. Thus, measuring PT is a critical component of managing patients on anticoagulant therapy to ensure safe and effective treatment.